NCT02378220 - Pharmacogenetic Testing Among Home Health Patients | Biotech Hunter

Enrollment

110

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

March 31, 2016

Conditions

Adverse Drug EventsAdverse Drug ReactionsDrug Interaction PotentiationDrug Metabolism, Poor, CYP2D6-RELATEDDrug Metabolism, Poor, CYP2C19-RELATEDCytochrome P450 Enzyme DeficiencyCytochrome P450 CYP2D6 Enzyme DeficiencyCytochrome P450 CYP2C9 Enzyme DeficiencyCytochrome P450 CYP2C19 Enzyme DeficiencyCytochrome P450 CYP3A Enzyme DeficiencyPoor Metabolizer Due to Cytochrome P450 CYP2C9 VariantPoor Metabolizer Due to Cytochrome p450 CYP2C19 VariantPoor Metabolizer Due to Cytochrome P450 CYP2D6 Variant

Interventions

GENETIC

Pharmacogenetic testing

Pharmacogenetic testing via YouScript® Personalized Prescribing System

Trial Locations (1)

72143

White County Medical Center Home Health, Searcy